Munder Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$292K Sell
29,200
-17,660
-38% -$181K ﹤0.01% 538
2014
Q2
$465K Sell
46,860
-900
-2% -$7.97K ﹤0.01% 523
2014
Q1
$494K Sell
47,760
-1,420
-3% -$14.7K ﹤0.01% 522
2013
Q4
$435K Sell
49,180
-12,320
-20% -$97.5K ﹤0.01% 528
2013
Q3
$434K Sell
61,500
-30,300
-33% -$192K ﹤0.01% 521
2013
Q2
$515K Buy
+91,800
New +$440K ﹤0.01% 489

Other funds holding DXCM

Munder Capital Management's DXCM Position: Q3 2014 in Review

Munder Capital Management reduced its DexCom (DXCM) stake by 38% in Q3 2014, selling an estimated $181K and leaving 29,200 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #538.

Munder Capital Management first reported a position in DXCM in Q2 2013 and has held it in 6 quarters since. The position peaked at $515K in Q2 2013. 200 funds tracked by Wall St. Rank hold DXCM as of Q3 2014.

  • Munder Capital Management held 29,200 shares of DexCom worth $292K as of Q3 2014.
  • Munder Capital Management sold 17,660 DexCom shares in Q3 2014, an estimated $181K.
  • DexCom made up ﹤0.01% of Munder Capital Management's portfolio in Q3 2014, its #538 holding.
  • Munder Capital Management first reported a position in DexCom in Q2 2013 and has held it in 6 quarters since.
  • Munder Capital Management's DexCom position peaked at $515K in Q2 2013.
  • 200 funds tracked by Wall St. Rank held DexCom as of Q3 2014.

Based on Munder Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.